Evidence map›Paper›PMID 39309850›Full record

ArticleHeliyon2024

Improving performance in colorectal cancer histology decomposition using deep and ensemble machine learning.

Fabi Prezja, Leevi Annala, Sampsa Kiiskinen, Suvi Lahtinen, Timo Ojala, Pekka Ruusuvuori, Teijo Kuopio

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fabi PrezjaUniversity of Jyväskylä, Faculty of Information Technology, Jyväskylä, 40014, Finland.
Leevi AnnalaUniversity of Helsinki, Faculty of Science, Department of Computer Science, Helsinki, Finland.
Sampsa KiiskinenUniversity of Jyväskylä, Faculty of Information Technology, Jyväskylä, 40014, Finland.
Suvi LahtinenUniversity of Jyväskylä, Faculty of Information Technology, Jyväskylä, 40014, Finland.
Timo OjalaUniversity of Jyväskylä, Faculty of Information Technology, Jyväskylä, 40014, Finland.
Pekka RuusuvuoriUniversity of Turku, Institute of Biomedicine, Cancer Research Unit, Turku, 20014, Finland.
Teijo KuopioUniversity of Jyväskylä, Department of Biological and Environmental Science, Jyväskylä, 40014, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In routine colorectal cancer management, histologic samples stained with hematoxylin and eosin are commonly used. Nonetheless, their potential for defining objective biomarkers for patient stratification and treatment selection is still being explored. The current gold standard relies on expensive and time-consuming genetic tests. However, recent research highlights the potential of convolutional neural networks (CNNs) to facilitate the extraction of clinically relevant biomarkers from these readily available images. These CNN-based biomarkers can predict patient outcomes comparably to golden standards, with the added advantages of speed, automation, and minimal cost. The predictive potential of CNN-based biomarkers fundamentally relies on the ability of CNNs to accurately classify diverse tissue types from whole slide microscope images. Consequently, enhancing the accuracy of tissue class decomposition is critical to amplifying the prognostic potential of imaging-based biomarkers. This study introduces a hybrid deep transfer learning and ensemble machine learning model that improves upon previous approaches, including a transformer and neural architecture search baseline for this task. We employed a pairing of the EfficientNetV2 architecture with a random forest classification head. Our model achieved 96.74% accuracy (95% CI: 96.3%-97.1%) on the external test set and 99.89% on the internal test set. Recognizing the potential of these models in the task, we have made them publicly available.

Indexed as

BiomarkersConvolutional Neural NetworksCRCDeep learningHistopathologyHybrid modelNeural Architecture SearchVision Transformer

Identifiers

PMID39309850
PMCPMC11415691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.